Found: 2
Select item for more details and to access through your institution.
Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized controlled trial.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 2, p. 402, doi. 10.1111/1756-185X.13244
- By:
- Publication type:
- Article
PCSK9 Inhibition: From Current Advances to Evolving Future.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 2972, doi. 10.3390/cells11192972
- By:
- Publication type:
- Article